Skip to main content

Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC – 16 12 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LEARNING TECHNOLOGIES GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Sciens Building Solutions Acquires Another San Antonio-area Company

Addition of J.W. Dielmann will expand Sciens platform across the United States, offering broader scope of business in the south Texas region SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) — Sciens Building Solutions (“Sciens”) today announced it has welcomed Bulverde-based J.W. Dielmann to its growing portfolio of companies. This is the latest acquisition announcement from Sciens and helps expand their presence in south Texas, while providing J.W. Dielmann and its customers with even deeper resources and expertise, as well as the ability to leverage Sciens’ growing footprint across North America. Sciens’ existing Fire Alarm Control Systems, in nearby San Antonio, will partner closely with the J.W. Dielmann team to create synergies and enhanced service for its valued customers. “I’m thrilled about J.W. Dielmann’s partnership with...

Continue reading

SCOR announces the successful placement of EUR 500 million Restricted Tier 1 Notes

Press release16 December 2024 – N° 23  NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE U.S. SECURITIES ACT OF 1933, AS AMENDED) OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.    SCOR announces the successful placement of EUR 500 million Restricted Tier 1 Notes    SCOR SE today announces that it has successfully completed the placement with institutional investors of perpetual fixed rate resettable restricted Tier 1 notes being eligible...

Continue reading

EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating its growth in the med-tech space

EssilorLuxottica signs an agreement to acquire Espansione Groupfor accelerating its growth in the med-tech space EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases    Paris, France (16 December 2024) – EssilorLuxottica announces that it has entered into an agreement for the acquisition of Espansione Group, an Italy-based company specialized in the design and manufacturing of non-invasive medical devices, protected by international patents, for the diagnosis and treatment of dry-eye, ocular surface and retinal diseases. Espansione Group is a med-tech pioneer delivering the highest medical standards in over 40 countries. with the photobiomodulation (PBM) technology – the Light Modulation Low-level Light Therapy...

Continue reading

CPP Announces Acquisition of MCA III Apartments in Los Angeles

The 20-unit property will preserve affordable housing for the south-central Los Angeles community LOS ANGELES , Dec. 16, 2024 (GLOBE NEWSWIRE) — CPP (Community Preservation Partners), a mission-driven affordable housing preservation developer, has announced the acquisition and planned renovation of MCA III Apartments, an affordable housing complex in Los Angeles. The property is situated in the highly desirable south-central region of Los Angeles, which has a significant demand for affordable housing. This is the seventh community in the greater Los Angeles region for CPP.MCA III Apartments is located nearby the desirable Baldwin Hills and Crenshaw neighborhoods, which offer residents convenient access to public transportation, groceries, and recreational activities. Originally built in 1958, the property has experienced significant...

Continue reading

CPP Announces Acquisition of Normandie Villas in Los Angeles

The project will preserve 25 affordable housing units for families in popular Adams Normandie neighborhood LOS ANGELES, Dec. 16, 2024 (GLOBE NEWSWIRE) — CPP (Community Preservation Partners), a mission-driven affordable housing preservation developer, has announced the acquisition and planned renovation of Normandie Villas, an affordable housing complex in Los Angeles. The property is situated in the highly desirable Adams Normandie neighborhood of Los Angeles. This is the sixth community in the greater Los Angeles region for CPP.Normandie Villas is located approximately one mile from the campus of the University of Southern California and five miles from downtown Los Angeles. The transit-oriented location allows residents easy access to a bus stop, grocery store, public park and elementary school. Originally built in 1983, the...

Continue reading

Agrify Corporation Closes on Acquisition of Señorita

TROY, Mich., Dec. 16, 2024 (GLOBE NEWSWIRE) — Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of branded innovative solutions for the cannabis and hemp industries, has closed on its previously announced acquisition of certain assets from Double or Nothing LLC, the owner and creator of the Señorita brand of hemp-derived THC (“HD9”) drinks. “This is great news for Agrify shareholders! We believe Señorita is the best tasting drink in the fastest growing, most exciting beverage category in the country,” said Agrify Chairman and Interim CEO Ben Kovler. “Cannabis-based beverages like Señorita deliver consumers an enjoyable experience without the downsides of alcohol. This high demand is propelling Señorita founders Joel Gott and Charles Bieler with the team towards innovation and product development...

Continue reading

Form 8.5 (EPT/RI) m- Warpaint London Plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Warpaint London Plc(c)        Name of the party to the offer with which exempt principal trader is connected: Warpaint London Plc(d)        Date dealing undertaken: 13 December 2024(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? Yes – Brand Architekts Group plc2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases...

Continue reading

Healthcare Analytical Testing Services Market to Surpass Valuation of USD 15.55 Billion by 2031 | SkyQuest Technology

The healthcare analytical testing services market is growing due to rising clinical trials, biosimilar focus, increased outsourcing, and the impact of COVID-19. Westford, USA, Dec. 15, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global healthcare analytical testing services market size will reach a value of USD 15.55 Billion by 2031, with a CAGR of 11.2% during the forecast period (2024-2031). The market’s main driving factors are the number of companies in the pharmaceutical and medical device industries that outsource analytical testing services, increased clinical trials in need of analytical testing, and the rising emphasis on biosimilars. The industry has grown as a result of the COVID-19 pandemic. Additionally, since the pandemic, the market has seen a quick development in medications and treatments for its prevention,...

Continue reading

Stem Cell Banking Market to Surpass Value of USD 18.65 Billion By 2031 | SkyQuest Technology

The stem cell banking market is growing due to advancements in cryopreservation, cell bank prep, monoclonal antibodies, and the rising adoption of stem cell therapy. Westford, USA, Dec. 15, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global stem cell banking market share will reach a value of USD 18.65 Billion by 2031, with a CAGR of 18.30% during the forecast period (2024-2031). As cryopreservation and cell bank preparation techniques are getting advanced, the stem cell banking market is expanding rapidly. Besides, the market is growing due to the increased application of stem cell treatment and the trend of monoclonal antibodies with effective biopharmaceuticals. Furthermore, with the fact that more couples are opting for children at a later stage in life, late parenting is on the rise, and it has generated interest in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.